DKK762.40
2.28% today
Copenhagen, Nov 26, 03:16 pm CET
ISIN
DK0062498333
Symbol
NOVO B
Sector
Industry

Novo Nordisk Target price 2024 - Analyst rating & recommendation

Novo Nordisk Classifications & Recommendation:

Buy
63%
Hold
25%
Sell
13%

Novo Nordisk Price Target

Target Price DKK989.84
Price DKK745.40
Potential
Number of Estimates 26
26 Analysts have issued a price target Novo Nordisk 2025 . The average Novo Nordisk target price is DKK989.84. This is higher than the current stock price. The highest price target is
DKK1,150.00 54.28%
register free of charge
, the lowest is
DKK560.00 24.87%
register free of charge
.
A rating was issued by 32 analysts: 20 Analysts recommend Novo Nordisk to buy, 8 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Novo Nordisk stock has an average upside potential 2025 of . Most analysts recommend the Novo Nordisk stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion DKK 232.26 286.54
31.26% 23.37%
EBITDA Margin 47.96% 49.59%
4.74% 3.41%
Net Margin 35.48% 34.72%
16.02% 2.13%

27 Analysts have issued a sales forecast Novo Nordisk 2024 . The average Novo Nordisk sales estimate is

DKK287b
Unlock
. This is
5.90% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
DKK291b 7.67%
Unlock
, the lowest is
DKK280b 3.42%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 DKK232b 31.26%
2024
DKK287b 23.37%
Unlock
2025
DKK344b 19.97%
Unlock
2026
DKK402b 17.01%
Unlock
2027
DKK442b 9.87%
Unlock
2028
DKK502b 13.53%
Unlock

19 Analysts have issued an Novo Nordisk EBITDA forecast 2024. The average Novo Nordisk EBITDA estimate is

DKK142b
Unlock
. This is
4.86% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
DKK145b 6.92%
Unlock
, the lowest is
DKK134b 1.30%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 DKK111b 37.47%
2024
DKK142b 27.59%
Unlock
2025
DKK172b 21.23%
Unlock
2026
DKK204b 18.21%
Unlock
2027
DKK214b 5.08%
Unlock
2028
DKK228b 6.63%
Unlock

EBITDA Margin

2023 47.96% 4.74%
2024
49.59% 3.41%
Unlock
2025
50.12% 1.07%
Unlock
2026
50.63% 1.02%
Unlock
2027
48.42% 4.37%
Unlock
2028
45.48% 6.07%
Unlock

19 Novo Nordisk Analysts have issued a net profit forecast 2024. The average Novo Nordisk net profit estimate is

DKK99.5b
Unlock
. This is
6.08% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
DKK102b 8.35%
Unlock
, the lowest is
DKK96.7b 3.06%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 DKK82.4b 52.28%
2024
DKK99.5b 20.73%
Unlock
2025
DKK125b 26.14%
Unlock
2026
DKK150b 19.82%
Unlock
2027
DKK168b 11.67%
Unlock
2028
DKK200b 19.30%
Unlock

Net Margin

2023 35.48% 16.02%
2024
34.72% 2.13%
Unlock
2025
36.50% 5.13%
Unlock
2026
37.38% 2.41%
Unlock
2027
37.99% 1.63%
Unlock
2028
39.92% 5.08%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share DKK 18.67 22.54
52.28% 20.73%
P/E 33.07
EV/Sales 11.42

19 Analysts have issued a Novo Nordisk forecast for earnings per share. The average Novo Nordisk <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

DKK22.54
Unlock
. This is
6.07% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
DKK23.02 8.33%
Unlock
, the lowest is
DKK21.90 3.06%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 DKK18.67 52.28%
2024
DKK22.54 20.73%
Unlock
2025
DKK28.43 26.13%
Unlock
2026
DKK34.07 19.84%
Unlock
2027
DKK38.05 11.68%
Unlock
2028
DKK45.39 19.29%
Unlock

P/E ratio

Current 35.08 17.94%
2024
33.07 5.73%
Unlock
2025
26.22 20.71%
Unlock
2026
21.88 16.55%
Unlock
2027
19.59 10.47%
Unlock
2028
16.42 16.18%
Unlock

Based on analysts' sales estimates for 2024, the Novo Nordisk stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

11.42
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
11.48
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 12.09 18.37%
2024
11.42 5.56%
Unlock
2025
9.52 16.65%
Unlock
2026
8.13 14.54%
Unlock
2027
7.40 8.99%
Unlock
2028
6.52 11.92%
Unlock

P/S ratio

Current 12.16 18.45%
2024
11.48 5.57%
Unlock
2025
9.57 16.65%
Unlock
2026
8.18 14.54%
Unlock
2027
7.44 8.99%
Unlock
2028
6.56 11.92%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today